Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)
CUSIP: 68403P203
Q3 2019 13F Holders as of 30 Sep 2019
- Security type / class
- Equity / Common Stock par value $0.012 per share
- Total 13F shares
- 759,036
- Total 13F value
- $2,420,000
- Share change
- -79,465
- SEC-reported price per share
- $3.19
- Number of holders
- 28
- Value change
- -$260,031
- Number of buys
- 10
- Number of sells
- 6
- Shares outstanding
- 41,050,760
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2019
Institutions
28
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2019
Previous quarter: Q2 2019
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2019
13F
Lead comparable stake: 0.86%
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 0.86%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
0.86%
RENAISSANCE TECHNOLOGIES LLC
0.39%
BlackRock Finance, Inc.
0.18%
JANE STREET GROUP, LLC
0.11%
BARCLAYS PLC
0.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
0.86%
|
$1,273,000
354,713 shares
|
— | 30 Jun 2019 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.39%
|
$568,000
158,098 shares
|
— | 30 Jun 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
0.18%
|
$267,000
74,291 shares
|
— | 30 Jun 2019 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.11%
|
$155,000
43,212 shares
|
— | 30 Jun 2019 |
| BARCLAYS PLC |
13F
Company
|
0.1%
|
$148,000
41,186 shares
|
— | 30 Jun 2019 |
| MORGAN STANLEY |
13F
Company
|
0.07%
|
$101,000
28,169 shares
|
— | 30 Jun 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
28
Shares
759,036
Rows available
28
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
26
Q3 2019 holders
28
Holder diff
2
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 value | Q3 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend